Effect of silodosin on specific urinary symptoms associated with benign prostatic hyperplasia: analysis of international prostate symptom scores in 2 phase III clinical studies

PURPOSE: Pooled results from 2 randomized, placebo-controlled, US phase III studies (NCT00224107, NCT00224120) showed that silodosin, a uroselective α-blocker, significantly improved International Prostate Symptom Scores (IPSS) in men with symptomatic benign prostatic hyperplasia (BPH). This analysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gittelman, Marc C, Marks, Leonard S, Hill, Lawrence A, Volinn, Weining, Hoel, Gary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818930/
https://www.ncbi.nlm.nih.gov/pubmed/24198629
http://dx.doi.org/10.2147/OAJU.S15333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818930/
https://www.ncbi.nlm.nih.gov/pubmed/24198629
http://dx.doi.org/10.2147/OAJU.S15333

Ejemplares similares